多学科青少年和年轻成人神经肿瘤临床:临床病例、实践挑战和未来展望。

IF 3.7 Q1 CLINICAL NEUROLOGY
Neuro-oncology advances Pub Date : 2025-04-11 eCollection Date: 2025-01-01 DOI:10.1093/noajnl/vdaf072
Christianne V Mojica, Thiago Pimentel Muniz, Xin Wang, Stephanie Baker, Kim Edelstein, Cheryl Kanter, Katherine Mileski, Candice Nguyen, Angela Sekely, Derek S Tsang, Cynthia Hawkins, Uri Tabori, Warren P Mason, Julie Bennett
{"title":"多学科青少年和年轻成人神经肿瘤临床:临床病例、实践挑战和未来展望。","authors":"Christianne V Mojica, Thiago Pimentel Muniz, Xin Wang, Stephanie Baker, Kim Edelstein, Cheryl Kanter, Katherine Mileski, Candice Nguyen, Angela Sekely, Derek S Tsang, Cynthia Hawkins, Uri Tabori, Warren P Mason, Julie Bennett","doi":"10.1093/noajnl/vdaf072","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The distinct tumor histopathology, molecular features, and psychosocial needs among adolescents and young adults (AYA) with brain tumors pose challenges within traditional healthcare systems. Establishing a multidisciplinary AYA neuro-oncology clinic has been proposed to address these gaps in care. This is the first study to describe the framework and patient profile of a multidisciplinary AYA neuro-oncology clinic in a quaternary cancer center in Canada.</p><p><strong>Methods: </strong>Clinic framework was outlined and patients seen from December 2022 to June 2024 were included. Demographic profiles, tumor characteristics, treatment details, clinical trial enrollment, and allied health referrals were collected. Barriers encountered were summarized.</p><p><strong>Results: </strong>The clinic is composed of specialists in pediatric and adult neuro-oncology with seamless referrals to neurosurgery, radiation oncology, and allied health teams. A total of 100 patients (males 54%, females 46%) were seen with a median age of 24 years. Pediatric-type low-grade glioma (PLGG) was the leading diagnosis. BRAF alterations were the primary molecular drivers. Twenty-nine patients received active neuro-oncology management in the clinic. Overall, 77 patients underwent at least one surgery, 31 patients received radiotherapy, and 43 patients received chemotherapy. Trametinib was the primary targeted treatment prescribed. Three patients were eligible and enrolled in clinical trials. Barriers identified included a lack of peer support groups and a paucity of available clinical trials.</p><p><strong>Conclusions: </strong>This study provides insight into the clinical profile of patients seen in a multidisciplinary AYA neuro-oncology clinic in Canada. Multidisciplinary care is feasible and integral in addressing the multifaceted needs of AYAs with brain tumors.</p>","PeriodicalId":94157,"journal":{"name":"Neuro-oncology advances","volume":"7 1","pages":"vdaf072"},"PeriodicalIF":3.7000,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12063081/pdf/","citationCount":"0","resultStr":"{\"title\":\"Multidisciplinary adolescent and young adult neuro-oncology clinic: Clinical cases, practice challenges, and future perspectives.\",\"authors\":\"Christianne V Mojica, Thiago Pimentel Muniz, Xin Wang, Stephanie Baker, Kim Edelstein, Cheryl Kanter, Katherine Mileski, Candice Nguyen, Angela Sekely, Derek S Tsang, Cynthia Hawkins, Uri Tabori, Warren P Mason, Julie Bennett\",\"doi\":\"10.1093/noajnl/vdaf072\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The distinct tumor histopathology, molecular features, and psychosocial needs among adolescents and young adults (AYA) with brain tumors pose challenges within traditional healthcare systems. Establishing a multidisciplinary AYA neuro-oncology clinic has been proposed to address these gaps in care. This is the first study to describe the framework and patient profile of a multidisciplinary AYA neuro-oncology clinic in a quaternary cancer center in Canada.</p><p><strong>Methods: </strong>Clinic framework was outlined and patients seen from December 2022 to June 2024 were included. Demographic profiles, tumor characteristics, treatment details, clinical trial enrollment, and allied health referrals were collected. Barriers encountered were summarized.</p><p><strong>Results: </strong>The clinic is composed of specialists in pediatric and adult neuro-oncology with seamless referrals to neurosurgery, radiation oncology, and allied health teams. A total of 100 patients (males 54%, females 46%) were seen with a median age of 24 years. Pediatric-type low-grade glioma (PLGG) was the leading diagnosis. BRAF alterations were the primary molecular drivers. Twenty-nine patients received active neuro-oncology management in the clinic. Overall, 77 patients underwent at least one surgery, 31 patients received radiotherapy, and 43 patients received chemotherapy. Trametinib was the primary targeted treatment prescribed. Three patients were eligible and enrolled in clinical trials. Barriers identified included a lack of peer support groups and a paucity of available clinical trials.</p><p><strong>Conclusions: </strong>This study provides insight into the clinical profile of patients seen in a multidisciplinary AYA neuro-oncology clinic in Canada. Multidisciplinary care is feasible and integral in addressing the multifaceted needs of AYAs with brain tumors.</p>\",\"PeriodicalId\":94157,\"journal\":{\"name\":\"Neuro-oncology advances\",\"volume\":\"7 1\",\"pages\":\"vdaf072\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-04-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12063081/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuro-oncology advances\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/noajnl/vdaf072\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-oncology advances","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/noajnl/vdaf072","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:青少年和青壮年(AYA)脑肿瘤患者独特的肿瘤组织病理学、分子特征和社会心理需求给传统医疗保健系统带来了挑战。建立一个多学科的AYA神经肿瘤学诊所已被提议解决这些护理差距。这是第一个描述加拿大第四系癌症中心多学科AYA神经肿瘤诊所的框架和患者概况的研究。方法:概述临床框架,纳入2022年12月至2024年6月就诊的患者。收集了人口统计资料、肿瘤特征、治疗细节、临床试验登记和联合健康转诊。总结了遇到的障碍。结果:该诊所由儿科和成人神经肿瘤学专家组成,无缝转诊到神经外科、放射肿瘤学和联合健康团队。共100例患者(男性54%,女性46%),中位年龄24岁。儿科型低级别胶质瘤(PLGG)是主要诊断。BRAF改变是主要的分子驱动因素。29例患者在临床接受了积极的神经肿瘤治疗。总的来说,77名患者接受了至少一次手术,31名患者接受了放疗,43名患者接受了化疗。曲美替尼是主要的靶向治疗处方。三名患者符合条件并参加了临床试验。确定的障碍包括缺乏同伴支持小组和缺乏可用的临床试验。结论:这项研究提供了对加拿大多学科AYA神经肿瘤诊所患者临床概况的深入了解。多学科护理是可行的,是解决AYAs与脑肿瘤的多方面需求的组成部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Multidisciplinary adolescent and young adult neuro-oncology clinic: Clinical cases, practice challenges, and future perspectives.

Background: The distinct tumor histopathology, molecular features, and psychosocial needs among adolescents and young adults (AYA) with brain tumors pose challenges within traditional healthcare systems. Establishing a multidisciplinary AYA neuro-oncology clinic has been proposed to address these gaps in care. This is the first study to describe the framework and patient profile of a multidisciplinary AYA neuro-oncology clinic in a quaternary cancer center in Canada.

Methods: Clinic framework was outlined and patients seen from December 2022 to June 2024 were included. Demographic profiles, tumor characteristics, treatment details, clinical trial enrollment, and allied health referrals were collected. Barriers encountered were summarized.

Results: The clinic is composed of specialists in pediatric and adult neuro-oncology with seamless referrals to neurosurgery, radiation oncology, and allied health teams. A total of 100 patients (males 54%, females 46%) were seen with a median age of 24 years. Pediatric-type low-grade glioma (PLGG) was the leading diagnosis. BRAF alterations were the primary molecular drivers. Twenty-nine patients received active neuro-oncology management in the clinic. Overall, 77 patients underwent at least one surgery, 31 patients received radiotherapy, and 43 patients received chemotherapy. Trametinib was the primary targeted treatment prescribed. Three patients were eligible and enrolled in clinical trials. Barriers identified included a lack of peer support groups and a paucity of available clinical trials.

Conclusions: This study provides insight into the clinical profile of patients seen in a multidisciplinary AYA neuro-oncology clinic in Canada. Multidisciplinary care is feasible and integral in addressing the multifaceted needs of AYAs with brain tumors.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.20
自引率
0.00%
发文量
0
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信